Example: Heart Attack

Clinical Trials on Dysentery, Bacillary

Total 42 results

NCT03527173

Completed

A Study to Evaluate the Efficacy, Safety and Immunogenicity of a Vaccine Designed to Protect Against Infection With Shigella Sonnei in Healthy Adults

Conditions: Dysentery, Bacillary
NCT02017899

Completed

A Phase 1, Dose Escalation Study, to Evaluate a New Shigella Sonnei Vaccine in Healthy Adults.

Conditions: Shigellosis
NCT02034500

Completed

Evaluate a New Shigella Sonnei Vaccine Administered Either by Intradermal, Intranasal or Intramuscular Route in Healthy Adults

Conditions: Shigellosis
NCT01399424

Withdrawn

Shigella Sonnei OSPC-rDT Conjugate Vaccine

Conditions: Shigellosis
NCT02388009

Completed

Safety and Tolerability of a Bioconjugate Vaccine Against Shigella Flexneri 2a

Conditions: Shigellosis
NCT04078022

Recruiting

Shigella CVD 30000: Study of Responses to Vaccination With Shigella Vaccine

Conditions: Shigella
NCT01531530

Completed

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection Using cGMP

Conditions: Shigella
NCT03089879

Completed

A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study

Conditions: Dysentery, Bacillary
NCT01509846

Completed

Safety Study of Inactivated Shigella Whole Cell Vaccine in Adults

Conditions: Shigellosis
NCT04056117

Recruiting

A Study to Determine If a New Shigella Vaccine is Safe, Induces Immunity and The Best Dose Among Kenyan Infants

Conditions: Shigellosis
NCT00866242

Terminated

Safety and Efficacy Challenge Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella: Phase IIb

Conditions: Shigella
NCT00866476

Terminated

Safety and Efficacy Study of CVD 1208S, a Live, Attenuated Oral Vaccine to Prevent Shigella Infection: Phase IIa

Conditions: Shigella
NCT01336699

Completed

Safety and Immunogenicity of Two Live, Attenuated Oral Shigella Sonnei Vaccines: WRSs2 and WRSs3

Conditions: Shigella Infection
NCT00485134

Completed

Shigella Flexneri 2a Invaplex 50 Vaccine Dose Finding and Assessment of Protection

Conditions: Shigellosis
NCT02676895

Completed

A Study of the Safety and Immune Response of 2 Doses of a New Shigella Vaccine in Kenyan Adults

Conditions: Shigella Sonnei Infection
NCT01369927

Completed

Shigella Sonnel O-SPC/rBRU Conjugate Vaccine

Conditions: Immunogenicity; Shigellosis
NCT03038243

Withdrawn

Safety, Immunogenicity and Efficacy Study of Inactivated Whole Cell Shigella Flexneri 2a Vaccine With and Without dmLT in Adults

Conditions: Shigella Sonnei Dysenteries
NCT00368316

Completed

Safety, Immunogenicity and Efficacy of Shigella Conjugate Vaccines in 1-4 Year Olds in Israel

Conditions: Shigellosis
NCT02445963

Completed

Safety and Immunogenicity of Artificial Invaplex (Shigella Flexneri 2a InvaplexAR)

Conditions: Shigellosis; Bacillary Dysentery
NCT00210288

Completed

Healthy Adult Volunteer Study for Two Doses of a Shigella Vaccine

Conditions: Shigella Infection
NCT04242264

Not yet recruiting

Phase 2 Shigella Vaccine and Challenge

Conditions: Immunisation; Shigella Infection
NCT02516683

Completed

The Long Term Clinical Course of Postinfectious Irritable Bowel Syndrome After Shigellosis; A 10 Year Follow up Study

Conditions: Shigella Sonnei Infection
NCT03778125

Enrolling by invitation

Multidrug Resistant Shigella Infection in Bangladesh

Conditions: Diarrhea; Shigella
NCT02646371

Completed

Phase 2b Challenge Study With the Bioconjugate Vaccine Flexyn2a

Conditions: Shigellosis
NCT01069471

Completed

Safety and Reactogenicity of Bioconjugate Vaccine to Prevent Shigella

Conditions: Shigellosis